Outcomes of Severely Obese Patients Supported by a Centrifugal-Flow Left Ventricular Assist Device. (Record no. 4777)

MARC details
000 -LEADER
fixed length control field 02519nam a22003497a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 191204s20192019 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1071-9164
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.cardfail.2019.10.013 [doi]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code S1071-9164(19)30502-0 [pii]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 31704196
245 ## - TITLE STATEMENT
Title Outcomes of Severely Obese Patients Supported by a Centrifugal-Flow Left Ventricular Assist Device.
251 ## - Source
Source Journal of Cardiac Failure. 2019 Nov 05
252 ## - Abbreviated Source
Abbreviated source J Card Fail. 2019 Nov 05
253 ## - Journal Name
Journal name Journal of cardiac failure
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2019
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2020
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status aheadofprint
266 ## - Date added to catalog
Date added to catalog 2019-12-04
520 ## - SUMMARY, ETC.
Abstract BACKGROUND: Ventricular assist devices provide improved outcomes for advanced heart failure patients, but their benefit in the severely obese is not well documented.
520 ## - SUMMARY, ETC.
Abstract CONCLUSIONS: Despite an increased risk of adverse events, severe obesity was not associated with reduced survival or quality of life. A better understanding of the risks and benefits of LVAD therapy in obese patients will help in the shared decision-making of the patient selection process. Copyright (c) 2019. Published by Elsevier Inc.
520 ## - SUMMARY, ETC.
Abstract METHODS: Patients enrolled in the HeartWare ADVANCE trial (n=382) were divided into two body mass index (BMI) groups. Patients with severe obesity (> 35 kg/m2) were compared to a control group with BMI <= 35 kg/m2. The association of BMI with survival was tested using Kaplan-Meier analysis and major adverse events were compared.
520 ## - SUMMARY, ETC.
Abstract RESULTS: At implantation, 48 (13%) of patients were severely obese. There was no difference in survival through two years of support between severely obese patients and the control group. Severely obese patients were at higher risk of driveline infection (p=0.01) and acute renal dysfunction (p=0.002). Both groups experienced similar improvements in quality of life. Functional capacity improved in both severely obese and control patients, although severely obese patients had smaller improvements than controls in their six-minute walk scores.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element IN PROCESS -- NOT YET INDEXED
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Heart & Vascular Institute
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Najjar, Samer S
790 ## - Authors
All authors Birks EJ, Ewald GA, Kiernan MS, Leadley K, Najjar SS, Patel CB, Uriel N, Vest AR
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.1016/j.cardfail.2019.10.013">https://dx.doi.org/10.1016/j.cardfail.2019.10.013</a>
Public note https://dx.doi.org/10.1016/j.cardfail.2019.10.013
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 12/04/2019   31704196 31704196 12/04/2019 12/04/2019 Journal Article

Powered by Koha